"Salivary Gland Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Tumors or cancer of the SALIVARY GLANDS.
| Descriptor ID |
D012468
|
| MeSH Number(s) |
C04.588.443.591.824 C07.465.565.824 C07.465.815.718
|
| Concept/Terms |
Salivary Gland Neoplasms- Salivary Gland Neoplasms
- Gland Neoplasm, Salivary
- Gland Neoplasms, Salivary
- Neoplasm, Salivary Gland
- Salivary Gland Neoplasm
- Neoplasms, Salivary Gland
Cancer of Salivary Gland- Cancer of Salivary Gland
- Salivary Gland Cancers
- Salivary Gland Cancer
- Cancer, Salivary Gland
- Cancers, Salivary Gland
- Cancer of the Salivary Gland
|
Below are MeSH descriptors whose meaning is more general than "Salivary Gland Neoplasms".
Below are MeSH descriptors whose meaning is more specific than "Salivary Gland Neoplasms".
This graph shows the total number of publications written about "Salivary Gland Neoplasms" by people in this website by year, and whether "Salivary Gland Neoplasms" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1998 | 1 | 0 | 1 |
| 1999 | 1 | 0 | 1 |
| 2000 | 0 | 1 | 1 |
| 2001 | 1 | 0 | 1 |
| 2002 | 1 | 0 | 1 |
| 2004 | 0 | 1 | 1 |
| 2005 | 1 | 0 | 1 |
| 2006 | 1 | 0 | 1 |
| 2007 | 1 | 0 | 1 |
| 2009 | 1 | 0 | 1 |
| 2010 | 2 | 0 | 2 |
| 2011 | 2 | 0 | 2 |
| 2015 | 4 | 0 | 4 |
| 2016 | 5 | 0 | 5 |
| 2017 | 2 | 0 | 2 |
| 2018 | 1 | 0 | 1 |
| 2019 | 3 | 1 | 4 |
| 2020 | 1 | 0 | 1 |
| 2021 | 3 | 0 | 3 |
| 2022 | 3 | 0 | 3 |
| 2023 | 1 | 0 | 1 |
| 2024 | 2 | 0 | 2 |
| 2025 | 4 | 0 | 4 |
| 2026 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Salivary Gland Neoplasms" by people in Profiles.
-
MDM2 Inhibition with Alrizomadlin (APG-115) in TP53 wild-type salivary gland cancers: a phase I clinical trial. Nat Commun. 2026 Mar 19; 17(1).
-
Novel RUNX1/2 fusions in unclassified cystic squamous salivary gland tumors: Possible expansion of the keratocystoma family. Ann Diagn Pathol. 2026 Apr; 81:152603.
-
Pleomorphic Adenoma with Epithelial Atypia, Apocrine Metaplasia, and/or In situ/Intracapsular Salivary Duct Carcinoma Are Indolent Lesions with Good Prognosis: A Proposal for Unified Nomenclature and Clinical Observation. Head Neck Pathol. 2025 Sep 12; 19(1):109.
-
Risk of malignancy associated with indeterminate categories in the Milan System for reporting pediatric salivary gland cytopathology: a multi-institutional study. J Am Soc Cytopathol. 2026 Jan-Feb; 15(1):39-45.
-
PRMT5 inhibition has a potent anti-tumor activity against adenoid cystic carcinoma of salivary glands. J Exp Clin Cancer Res. 2025 Jan 11; 44(1):11.
-
Update of newly-recognized salivary gland neoplasms: molecular and immunohistochemical findings and clinical importance. Histopathology. 2025 Jan; 86(2):183-198.
-
Oncologic Safety of Close Margins in Patients With Low- to Intermediate-Grade Major Salivary Gland Carcinoma. JAMA Otolaryngol Head Neck Surg. 2024 02 01; 150(2):107-116.
-
Top 10 Clear Cell Head and Neck Lesions to Contemplate. Head Neck Pathol. 2023 Mar; 17(1):33-52.
-
Secretory carcinoma of the salivary gland: a multi-institutional clinicopathologic study of 90 cases with emphasis on grading and prognostic factors. Histopathology. 2022 Nov; 81(5):670-679.
-
AL101, a gamma-secretase inhibitor, has potent antitumor activity against adenoid cystic carcinoma with activated NOTCH signaling. Cell Death Dis. 2022 08 05; 13(8):678.